Back to search

Article

<i>In silico</i> transcriptomics identifies FDA-approved drugs and biological pathways for protection against cisplatin-induced hearing loss

2022-01-28

Abstract excerpt

Acquired hearing loss is a major health problem that affects 5-10% of the world population. However, there are no FDA-approved drugs for the treatment or prevention of hearing loss. Employing the Connectivity Map (CMap) that contains >54,000 compounds, we performed an unbiased in silico screen using the transcriptomic profiles of cisplatin-resistant and -sensitive cancer cell lines. Pathway enrichment analysis id...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d445b43f-d94a-58ea-ba5b-941efd51ac89
DOI
10.1101/2022.01.26.477836
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
<i>In silico</i> transcriptomics identifies FDA-approved drugs and biological pathways for protection against cisplatin-induced hearing lossDOI 10.1101/2022.01.26.477836
Select a neighboring publication to make it the new centre.